Quadrature Capital LTD Danaher Corp Transaction History

Quadrature Capital LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $3.46 Million - $3.94 Million	-15,376 Reduced 24.3%	47,899 $11.5 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $15.2 Million - $17.5 Million	63,275 New	63,275 $15.9 Million
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $761,519 - $934,649	-2,960 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $864,556 - $973,869	2,960 New	2,960 $974,000
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $4.32 Million - $5.22 Million	-19,196 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$212.38 - $245.9 $1.38 Million - $1.6 Million	6,491 Added 51.09%	19,196 $4.32 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $1.78 Million - $2.06 Million	8,376 Added 193.49%	12,705 $2.82 Million
Q1 2020 May 15, 2020	SELL	$121.39 - $169.05 $2.76 Million - $3.85 Million	-22,763 Reduced 84.02%	4,329 $599,000
Q2 2018 Aug 10, 2018	BUY	$96.1 - $103.24 $2.22 Million - $2.39 Million	23,104 Added 579.34%	27,092 $0
Q1 2018 May 11, 2018	BUY	$92.16 - $103.8 $367,534 - $413,954	3,988 New	3,988 $0

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.